Philipp Schommers

5.9k total citations · 1 hit paper
31 papers, 872 citations indexed

About

Philipp Schommers is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Philipp Schommers has authored 31 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 12 papers in Virology and 5 papers in Molecular Biology. Recurrent topics in Philipp Schommers's work include HIV Research and Treatment (12 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Viral-associated cancers and disorders (5 papers). Philipp Schommers is often cited by papers focused on HIV Research and Treatment (12 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Viral-associated cancers and disorders (5 papers). Philipp Schommers collaborates with scholars based in Germany, United States and France. Philipp Schommers's co-authors include Henning Gruell, Florian Klein, Florian Kurth, Kanika Vanshylla, Clara Lehmann, Pinkus Tober‐Lau, Leif Erik Sander, David Hillus, Christoph Kreer and Lutz Gieselmann and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Philipp Schommers

29 papers receiving 862 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant

2022 243 citations Henning Gruell, Kanika Vanshylla et al. Nature Medicine profile →

Peers

Philipp Schommers

IMMUN

ONCOL

VIROL

For Yue Tso United States

Maura Manion United States

Dominik Nörz Germany

Nuanjun Wichukchinda Thailand

Roberta Placido Italy

Jianqi Lian China

Armando Del Portillo United States

Jesper Falkesgaard Højen Denmark

Sandeep Narpala United States

Simone Topino Italy

For Yue Tso United States

Philipp Schommers

245 ×0.5

75 ×0.4

78 ×0.5

IMMUN

155 ×1.1

ONCOL

84 ×0.6

VIROL

Citations per year, relative to Philipp Schommers Philipp Schommers (= 1×) peers For Yue Tso

Countries citing papers authored by Philipp Schommers

Since Specialization

Citations

This map shows the geographic impact of Philipp Schommers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philipp Schommers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philipp Schommers more than expected).

Fields of papers citing papers by Philipp Schommers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philipp Schommers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philipp Schommers. The network helps show where Philipp Schommers may publish in the future.

Co-authorship network of co-authors of Philipp Schommers

This figure shows the co-authorship network connecting the top 25 collaborators of Philipp Schommers. A scholar is included among the top collaborators of Philipp Schommers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philipp Schommers. Philipp Schommers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Suárez, Isabelle, Melanie Stecher, Clara Lehmann, et al.. (2024). Incidence and risk factors for HIV-tuberculosis coinfection in the Cologne–Bonn region: a retrospective cohort study. Infection. 52(4). 1439–1448. 3 indexed citations

Gruell, Henning, et al.. (2024). Therapeutic interfering particles against HIV: molecular parasites reducing viremia. Signal Transduction and Targeted Therapy. 9(1). 287–287. 1 indexed citations

Lehmann, Clara & Philipp Schommers. (2024). The need for novel approaches to HIV-1 vaccine development. The Lancet Infectious Diseases. 24(11). 1178–1179. 1 indexed citations

Malin, Jakob J, Isabelle Suárez, Lena M. Biehl, et al.. (2023). Immune response to mRNA‐based COVID‐19 booster vaccination in people living with HIV. HIV Medicine. 24(7). 785–793. 4 indexed citations

Radford, Caelan E., Philipp Schommers, Lutz Gieselmann, et al.. (2023). Mapping the neutralizing specificity of human anti-HIV serum by deep mutational scanning. Cell Host & Microbe. 31(7). 1200–1215.e9. 17 indexed citations

Augustin, Max, Melanie Stecher, Veronica Di Cristanziano, et al.. (2023). 15-month post-COVID syndrome in outpatients: Attributes, risk factors, outcomes, and vaccination status - longitudinal, observational, case-control study. Frontiers in Immunology. 14. 1226622–1226622. 3 indexed citations

Kreer, Christoph, Meryem S. Ercanoglu, Lutz Gieselmann, et al.. (2023). Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals. Nature Communications. 14(1). 7137–7137. 7 indexed citations

Barnes, Christopher O., Till Schoofs, Priyanthi N.P. Gnanapragasam, et al.. (2022). A naturally arising broad and potent CD4-binding site antibody with low somatic mutation. Science Advances. 8(32). eabp8155–eabp8155. 10 indexed citations

Kehl, Victoria, Johanna Erber, Kilian Schober, et al.. (2022). CMV seropositivity is a potential novel risk factor for severe COVID-19 in non-geriatric patients. PLoS ONE. 17(5). e0268530–e0268530. 20 indexed citations

10.

Gruell, Henning, Kanika Vanshylla, Pinkus Tober‐Lau, et al.. (2022). mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant. Nature Medicine. 28(3). 477–480. 243 indexed citations breakdown →

11.

Gruell, Henning, Kanika Vanshylla, Michael Korenkov, et al.. (2022). SARS-CoV-2 Omicron sublineages exhibit distinct antibody escape patterns. Cell Host & Microbe. 30(9). 1231–1241.e6. 46 indexed citations

12.

Gruell, Henning & Philipp Schommers. (2022). Broadly neutralizing antibodies against HIV-1 and concepts for application. Current Opinion in Virology. 54. 101211–101211. 21 indexed citations

13.

Gieselmann, Lutz, Christoph Kreer, Meryem S. Ercanoglu, et al.. (2021). Effective high-throughput isolation of fully human antibodies targeting infectious pathogens. Nature Protocols. 16(7). 3639–3671. 31 indexed citations

14.

Kreer, Christoph, Matthias Döring, Meryem S. Ercanoglu, et al.. (2020). openPrimeR for multiplex amplification of highly diverse templates. Journal of Immunological Methods. 480. 112752–112752. 22 indexed citations

15.

Schoofs, Till, Christopher O. Barnes, Jovana Golijanin, et al.. (2019). Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope. Immunity. 50(6). 1513–1529.e9. 57 indexed citations

16.

Stecher, Melanie, Philipp Schommers, Daniel Schmidt, et al.. (2018). Antiretroviral treatment indications and adherence to the German-Austrian treatment initiation guidelines in the German ClinSurv HIV Cohort between 1999 and 2016. Infection. 47(2). 247–255. 5 indexed citations

17.

Schommers, Philipp, Daniel Gillor, Marcus Hentrich, et al.. (2018). Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study. Haematologica. 103(5). 857–864. 22 indexed citations

18.

Körner, Christian, Camille R. Simoneau, Philipp Schommers, et al.. (2017). HIV-1-Mediated Downmodulation of HLA-C Impacts Target Cell Recognition and Antiviral Activity of NK Cells. Cell Host & Microbe. 22(1). 111–119.e4. 30 indexed citations

19.

Schommers, Philipp, Maria Guschlbauer, Andreas R. Klatt, et al.. (2017). Metformin causes a futile intestinal–hepatic cycle which increases energy expenditure and slows down development of a type 2 diabetes-like state. Molecular Metabolism. 6(7). 737–747. 30 indexed citations

20.

Schommers, Philipp, Christoph Wyen, Marcus Hentrich, et al.. (2013). Poor outcome of HIV-infected patients with plasmablastic lymphoma. AIDS. 27(5). 842–845. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact